Skip to main content
SpringerLink
Log in

Management von inadäquaten Schocks/T-Wellen-Oversensing bei S-ICD®-Patienten

Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients

  • Übersichten
  • Published:
Herzschrittmachertherapie + Elektrophysiologie Aims and scope Submit manuscript

Zusammenfassung

Inadäquate Schockabgaben sind eine gefürchtete Komplikation bei Patienten nach Implantation eines Kardioverter-Defibrillators, welche die Lebensqualität der betroffenen Patienten sehr stark beeinträchtigt. Die Ursachen von inadäquaten Schockabgaben beim subkutanen ICD (S-ICD®, Boston Scientific, Marlborough, MA, USA) sind vielfältig. Diese Übersichtsarbeit fasst die aktuelle Literatur zu diesem Thema zusammen und zeigt mögliche Behandlungsstrategien.

Abstract

Inappropriate shocks are a feared complication after implantable cardioverter–defibrillator (ICD) implantation and have a tremendous impact on quality of life. Inappropriate shocks in patients with subcutaneous ICD (S-ICD®, Boston Scientific, Marlborough, MA, USA) have various underlying causes. This review summarizes the current literature on this topic and lists possible treatment options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB et al (2014) Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S‑ICD Registry. Eur Heart J 35:1657–1665

    Article  PubMed  PubMed Central  Google Scholar 

  2. Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P et al (2017) Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol 70:830–841

    Article  PubMed  Google Scholar 

  3. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J et al (2015) ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015(36):2793–2867

    Article  Google Scholar 

  4. Kobe J, Hucklenbroich K, Geisendorfer N, Bettin M, Frommeyer G, Reinke F et al (2016) Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems. Clin Res Cardiol 106(5):317–321. https://doi.org/10.1007/s00392-016-1055-0

    Article  PubMed  Google Scholar 

  5. Kooiman KM, Knops RE, Nordkamp OL, Wilde AA, de Groot JR (2014) Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T‑wave oversensing can be prevented: implications for management. Heart Rhythm 11:426–434

    Article  PubMed  Google Scholar 

  6. Nordkamp OLR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ et al (2012) The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 60:1933–1939

    Article  Google Scholar 

  7. Boveda S, Lenarczyk R, Haugaa K, Fumagalli S, Madrid AH, Defaye P et al (2016) Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey. Europace 18:1434–1439

    Article  PubMed  Google Scholar 

  8. Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Nordkamp OLR, Schalij MJ et al (2016) Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol 68:2047–2055

    Article  PubMed  Google Scholar 

  9. Sousa MJ, Betts T (2017) Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block. J Arrhythm 33:73–75

    Article  PubMed  Google Scholar 

  10. Lambiase PD, Gold MR, Hood M, Boersma L, Theuns DA, Burke MC et al (2016) Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts. heart Rhythm 13:1066–1074

    Article  PubMed  Google Scholar 

  11. Frommeyer G, Dechering DG, Zumhagen S, Loher A, Kobe J, Eckardt L et al (2016) Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience. Clin Res Cardiol 105:89–93

    Article  PubMed  Google Scholar 

  12. Batul SA, Yang F, Wats K, Shrestha S, Greenberg YJ (2017) Inappropriate subcutaneous implantable cardioverter-defibrillator therapy due to R‑wave amplitude variation: another challenge in device management. HeartRhythm Case Rep 3:78–82

    Article  PubMed  Google Scholar 

  13. Maurizi N, Olivotto I, Nordkamp OLR, Baldini K, Fumagalli C, Brouwer TF et al (2016) Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy. Heart Rhythm 13(63):457

    Article  PubMed  Google Scholar 

  14. Srinivasan NT, Patel KH, Qamar K, Taylor A, Baca M, Providencia R et al (2017) Disease severity and exercise testing reduce subcutaneous implantable cardioverter-defibrillator left sternal ECG screening success in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol 10(4):e4801. https://doi.org/10.1161/CIRCEP.117.004801

    Article  PubMed  Google Scholar 

  15. Maurizi N, Tanini I, Olivotto I, Amendola E, Limongelli G, Losi MA et al (2017) Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy. Int J Cardiol 231:115–119

    Article  PubMed  Google Scholar 

  16. Morani G, Bolzan B, Tomasi L, Tomei R, Vassanelli C (2017) Pitfalls in electrogram interpretation: subcutaneous cardioverter defibrillator malfunction in brugada syndrome. Pacing Clin Electrophysiol 40(10):1180–1183. https://doi.org/10.1111/pace.13091

    Article  PubMed  Google Scholar 

  17. Kamakura T, Wada M, Ishibashi K, Inoue YY, Miyamoto K, Okamura H et al (2017) Impact of electrocardiogram screening during drug challenge test for the prediction of T‑wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome. Heart Vessels 32(10):1277–1283. https://doi.org/10.1007/s00380-017-0994-3

    Article  PubMed  Google Scholar 

  18. El-Chami MF, Harbieh B, Levy M, Leon AR, Merchant FM (2016) Clinical and electrocardiographic predictors of T wave oversensing in patients with subcutaneous ICD. J Arrhythm 32:181–185

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA et al (2012) Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol 23:359–366

    Article  PubMed  Google Scholar 

  20. Bettin M, Larbig R, Rath B, Fischer A, Frommeyer G, Reinke F, Koebe J, Eckardt L (2017) Long-term experience with the subcutaneous ICD in teenagers and young adults. JACC Clin Electrophysiol. https://doi.org/10.1016/j.jacep.2017.08.017

    Google Scholar 

  21. Frommeyer G, Dechering DG, Kochhauser S, Bettin M, Koebe J, Eckardt L et al (2016) Long-time „real-life“ performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation. J Interv Card Electrophysiol 47:185–188

    Article  PubMed  Google Scholar 

  22. Nordkamp OLR, Brouwer TF, Barr C, Theuns DA, Boersma LV, Johansen JB et al (2015) Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management. int J Cardiol 195:126–133

    Article  Google Scholar 

  23. Afzal MR, Evenson C, Badin A, Patel D, Godara H, Essandoh M et al (2017) Role of exercise electrocardiogram to screen for T‑wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 14(10):1436–1439. https://doi.org/10.1016/j.hrthm.2017.06.022

    Article  PubMed  Google Scholar 

  24. Cohen MI, Shaffer J, Pedersen S, Sims JJ, Papez A (2011) Limited utility of exercise-stress testing to prevent T‑wave oversensing in pediatric internal cardioverter defibrillator recipients. Pacing Clin Electrophysiol 34:436–442

    Article  PubMed  Google Scholar 

  25. Brisben AJ, Burke MC, Knight BP, Hahn SJ, Herrmann KL, Allavatam V et al (2015) A new algorithm to reduce inappropriate therapy in the S‑ICD system. J Cardiovasc Electrophysiol 26:417–423

    Article  PubMed  Google Scholar 

  26. Gold MR, Weiss R, Theuns DA, Smith W, Leon A, Knight BP et al (2014) Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. heart Rhythm 11:1352–1358

    Article  PubMed  Google Scholar 

  27. Clementy N, Challal F, Marijon E, Boveda S, Defaye P, Leclercq C et al (2017) Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study. Heart Rhythm 14:211–217

    Article  PubMed  Google Scholar 

  28. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J et al (2016) 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace 18:159–183

    Article  PubMed  Google Scholar 

  29. Sovari AA, Ehdaie A, Liu Q, Wang X, Swerdlow C, Shehata M (2017) Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing. HeartRhythm Case Rep 3:133–136

    Article  PubMed  Google Scholar 

  30. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP et al (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367:2275–2283

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Electrophysiology, Department of Cardiovascular Medicine, University of Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149, Münster, Deutschland

    Robert Larbig,  Markus Bettin,  Alicia Fischer,  Niklas Bode,  Gerrit Frommeyer,  Florian Reinke,  Lars Eckardt &  Julia Köbe

  2. Department of Internal Medicine II, Paracelsus Medical University, Salzburg, Österreich

    Lukas J. Motloch

  3. Department of Cardiac and Thoracic Surgery, University of Muenster, Albert-Schweitzer- Campus 1, Building A1, 48149, Muenster, Deutschland

    Andreas Loeher

Authors
  1. Robert Larbig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Markus Bettin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lukas J. Motloch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alicia Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Niklas Bode
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gerrit Frommeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Florian Reinke
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andreas Loeher
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lars Eckardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Julia Köbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert Larbig.

Ethics declarations

Interessenkonflikt

Die Drs. M. Bettin, F. Reinke, J. Köbe, und, L. Eckardt haben Reisestipendien und Vortragshonorare von Biotronik, Boston Scientific, Medtronic, LivaNova, und St. Jude Medical erhalten. Drs. F. Reinke und L. Eckardt waren beide Mitglieder des Advisory Board von Cameron Health. R. Larbig, L.J. Motloch, A. Fischer, N. Bode, G. Frommeyer und A. Loeher geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

R. Larbig, M. Bettin, L.J. Motloch haben zu gleichen Teilen zu diesem Artikel beigetragen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Larbig, R., Bettin, M., Motloch, L.J. et al. Management von inadäquaten Schocks/T-Wellen-Oversensing bei S-ICD®-Patienten. Herzschr Elektrophys 29, 122–126 (2018). https://doi.org/10.1007/s00399-018-0555-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00399-018-0555-1

Schlüsselwörter

Keywords

Search

Navigation